ethz-慢性淋巴细胞白血病对伊布替尼的适应是由残留疾病的表观遗传可塑性和通过旁路信号介导 Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib is Mediated by Epigenetic Plasticity of Residual Disease and By-Pass Signaling via Mapk.pdfVIP

  • 0
  • 0
  • 约32.99万字
  • 约 110页
  • 2026-07-14 发布于广东
  • 举报

ethz-慢性淋巴细胞白血病对伊布替尼的适应是由残留疾病的表观遗传可塑性和通过旁路信号介导 Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib is Mediated by Epigenetic Plasticity of Residual Disease and By-Pass Signaling via Mapk.pdf

ETHLibrary

AdaptationofChronicLymphocytic

LeukemiatoIbrutinibisMediated

byEpigeneticPlasticityofResidual

DiseaseandBy-PassSignalingvia

Mapk

DoctoralThesis

Author(s):

TerzidiBergamo,Lodovico

Publicationdate:

2026

Permanentlink:

//10.3929/ethz-c-000800144

Rights/license:

InCopyright-Non-CommercialUsePermitted

ThispagewasgeneratedautomaticallyupondownloadfromtheETHZurichResearchCollectio

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档